PRoMPT BOLUS

PRoMPT BOLUS

Contact

 If you are interested in participating in the study or want to learn more, please contact: Contact us
This study is no longer recruiting.

Description
PRoMPT BOLUS will determine which of two commonly used IV fluid types is most effective to treat children with sepsis. Patients with possible septic shock will be treated with one of two types of IV fluid, both of which are part of standard of care--0.9% saline or balanced fluids (including lactated Ringer’s solution or Plasma-Lyte)--along with the best locally available medical care available for their symptoms. Because sepsis is an emergency, patients may be enrolled with “exception from informed consent” unless they opt-out. However, subjects/families will decide if their data can be used in the study. We are not aware of any reason, at this time, why anyone with sepsis would not choose to participate if awake and able to take part in decisions about their care.

Eligibility and criteria
IRB Number:
19-016484
Eligible age range:
6 months - 17 years
Clinical trial phase:
Phase III
Official title:
Balanced Fluid Resuscitation to Decrease Kidney Injury in Children with Septic Shock

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.